A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

NCT06321250 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma Metastatic

Interventions

DRUG: JMKX003948

Sponsor

Jemincare

Collaborators

[object Object]